LINCOLN PHARMA LTD

LINCOLN

Small Cap | Pharmaceuticals
460.5
-0.6 (-0.13%)

Stock price as on 06 Feb 2026 at 15:29 PM

Lincoln pharma ltd share price update

As of the latest trading session, Lincoln Pharma Ltd share price is currently at ₹460.5, which is down by ₹-0.6 from its previous closing. Today the s...

Lincoln Pharma Ltd stock performance

Today’s low

₹452.9

Today’s high

₹460.55

₹460.5

52 week low

₹440

52 week high

₹808.8

₹460.5
Open
₹460.00
Previous close
₹461.10
Share volume
8,356
Total traded value (Lakh)
₹38.42
Upper circuit
₹553.30
Lower circuit
₹368.90

Lincoln Pharma Ltd fundamentals

Market cap (Cr)
₹921.00
P/E ratio (TTM)
11.54
Book value per share
₹357.35
Beta
0.95
Return on equity
13.02%
Earnings per share (TTM)
₹39.94
Dividend yield
0.39%
Net profit/quarter (Cr)
₹19.98

Lincoln Pharma Ltd financials

(Values in Cr)
Revenue
Net income

Particulars

Sep 25 (₹ value in crores)

Revenue

₹163.36

Operating expense

₹141.78

Net income

₹19.98

Net profit margin

12.23%

Earning per share

₹9.98

EBITDA

₹32.66

Effective tax rate

30.64%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹154.07

Operating expense

₹133.95

Net income

₹27.68

Net profit margin

17.96%

Earning per share

₹13.82

EBITDA

₹39.08

Effective tax rate

21.78%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹168.18

Operating expense

₹145.06

Net income

₹11.58

Net profit margin

6.88%

Earning per share

₹5.78

EBITDA

₹19.85

Effective tax rate

28.73%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹146.55

Operating expense

₹126.84

Net income

₹20.77

Net profit margin

14.17%

Earning per share

₹10.37

EBITDA

₹32.63

Effective tax rate

27.58%

Particulars

Sep 24 (₹ value in crores)

Revenue

₹161.21

Operating expense

₹136.41

Net income

₹26.33

Net profit margin

16.33%

Earning per share

₹13.15

EBITDA

₹38.35

Effective tax rate

24.29%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹623.23

Operating expense

₹536.52

Net income

₹82.35

Net profit margin

13.21%

Earning per share

₹41.11

EBITDA

₹123.97

Effective tax rate

24.58%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹580.55

Operating expense

₹492.72

Net income

₹93.30

Net profit margin

16.07%

Earning per share

₹46.58

EBITDA

₹134.32

Effective tax rate

23.67%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹510.31

Operating expense

₹432.34

Net income

₹72.90

Net profit margin

14.28%

Earning per share

₹36.40

EBITDA

₹111.66

Effective tax rate

27.43%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹472.08

Operating expense

₹386.15

Net income

₹69.36

Net profit margin

14.69%

Earning per share

₹34.63

EBITDA

₹105.47

Effective tax rate

27.69%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹422.91

Operating expense

₹344.98

Net income

₹62.25

Net profit margin

14.71%

Earning per share

₹31.08

EBITDA

₹92.78

Effective tax rate

25.6%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹335.34

Return on Equity (ROE)

13.02%

Return on Capital Employed (ROCE)

17.42%

Total debt to equity ratio

-

EBITDA margin

19.89%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹295.98

Return on Equity (ROE)

17.04%

Return on Capital Employed (ROCE)

22.35%

Total debt to equity ratio

-

EBITDA margin

23.14%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹250.86

Return on Equity (ROE)

15.59%

Return on Capital Employed (ROCE)

21.61%

Total debt to equity ratio

-

EBITDA margin

21.88%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹216.12

Return on Equity (ROE)

17.36%

Return on Capital Employed (ROCE)

24.03%

Total debt to equity ratio

-

EBITDA margin

22.34%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹182.92

Return on Equity (ROE)

18.32%

Return on Capital Employed (ROCE)

24.6%

Total debt to equity ratio

0.01

EBITDA margin

21.89%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹335.34

Return on Equity (ROE)

13.02%

Return on Capital Employed (ROCE)

17.42%

Total debt to equity ratio

-

EBITDA margin

19.89%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹295.98

Return on Equity (ROE)

17.04%

Return on Capital Employed (ROCE)

22.35%

Total debt to equity ratio

-

EBITDA margin

23.14%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹250.86

Return on Equity (ROE)

15.59%

Return on Capital Employed (ROCE)

21.6%

Total debt to equity ratio

-

EBITDA margin

21.88%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹216.12

Return on Equity (ROE)

17.35%

Return on Capital Employed (ROCE)

24.02%

Total debt to equity ratio

-

EBITDA margin

22.34%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹182.92

Return on Equity (ROE)

18.56%

Return on Capital Employed (ROCE)

24.9%

Total debt to equity ratio

0.01

EBITDA margin

21.94%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹22.43

Total assets

₹797.00

Total liabilities

₹797.00

Total equity

₹671.66

Shares outstanding

₹2.00

Price to book ratio

₹1.64

Return on assets (%)

10.33%

Return on capital

12.26%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹13.83

Total assets

₹700.29

Total liabilities

₹700.29

Total equity

₹592.83

Shares outstanding

₹2.00

Price to book ratio

₹1.98

Return on assets (%)

13.32%

Return on capital

15.71%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹34.31

Total assets

₹587.42

Total liabilities

₹587.42

Total equity

₹502.47

Shares outstanding

₹2.00

Price to book ratio

₹1.35

Return on assets (%)

12.41%

Return on capital

14.45%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹18.79

Total assets

₹534.35

Total liabilities

₹534.35

Total equity

₹432.87

Shares outstanding

₹2.00

Price to book ratio

₹1.44

Return on assets (%)

12.97%

Return on capital

15.95%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹13.84

Total assets

₹452.35

Total liabilities

₹452.35

Total equity

₹366.39

Shares outstanding

₹2.00

Price to book ratio

₹1.23

Return on assets (%)

13.76%

Return on capital

16.97%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹21.99

Total assets

₹796.86

Total liabilities

₹796.86

Total equity

₹671.66

Shares outstanding

₹2.00

Price to book ratio

₹1.64

Return on assets (%)

10.33%

Return on capital

12.26%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹13.38

Total assets

₹700.14

Total liabilities

₹700.14

Total equity

₹592.83

Shares outstanding

₹2.00

Price to book ratio

₹1.98

Return on assets (%)

13.32%

Return on capital

15.71%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹33.84

Total assets

₹587.25

Total liabilities

₹587.25

Total equity

₹502.47

Shares outstanding

₹2.00

Price to book ratio

₹1.35

Return on assets (%)

12.41%

Return on capital

14.45%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹18.43

Total assets

₹534.11

Total liabilities

₹534.11

Total equity

₹432.87

Shares outstanding

₹2.00

Price to book ratio

₹1.44

Return on assets (%)

12.98%

Return on capital

15.95%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹13.43

Total assets

₹451.80

Total liabilities

₹451.80

Total equity

₹366.39

Shares outstanding

₹2.00

Price to book ratio

₹1.23

Return on assets (%)

13.77%

Return on capital

16.97%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹109.18

Cash from operations

₹119.32

Cash from investing

-₹78.94

Cash from financing

-₹6.40

Net change in cash

₹7.66

Free cash flow

₹138.35

Particulars

Mar 24 (₹ value in crores)

Net income

₹122.24

Cash from operations

₹89.36

Cash from investing

-₹57.34

Cash from financing

-₹5.18

Net change in cash

₹0.69

Free cash flow

₹128.84

Particulars

Mar 23 (₹ value in crores)

Net income

₹100.47

Cash from operations

₹68.87

Cash from investing

-₹36.64

Cash from financing

-₹4.50

Net change in cash

-₹1.88

Free cash flow

₹83.13

Particulars

Mar 22 (₹ value in crores)

Net income

₹95.93

Cash from operations

₹99.82

Cash from investing

-₹78.08

Cash from financing

-₹2.55

Net change in cash

-₹4.50

Free cash flow

₹145.35

Particulars

Mar 21 (₹ value in crores)

Net income

₹83.72

Cash from operations

₹88.76

Cash from investing

-₹64.22

Cash from financing

-₹5.74

Net change in cash

-₹0.70

Free cash flow

₹97.51

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹109.18

Cash from operations

₹119.32

Cash from investing

-₹78.94

Cash from financing

-₹6.40

Net change in cash

₹7.66

Free cash flow

₹138.35

Particulars

Mar 24 (₹ value in crores)

Net income

₹122.24

Cash from operations

₹89.37

Cash from investing

-₹57.34

Cash from financing

-₹5.17

Net change in cash

₹0.72

Free cash flow

₹128.84

Particulars

Mar 23 (₹ value in crores)

Net income

₹100.45

Cash from operations

₹68.76

Cash from investing

-₹36.64

Cash from financing

-₹4.50

Net change in cash

-₹1.98

Free cash flow

₹83.02

Particulars

Mar 22 (₹ value in crores)

Net income

₹95.92

Cash from operations

₹99.82

Cash from investing

-₹78.08

Cash from financing

-₹2.56

Net change in cash

-₹4.46

Free cash flow

₹145.34

Particulars

Mar 21 (₹ value in crores)

Net income

₹83.67

Cash from operations

₹88.84

Cash from investing

-₹64.39

Cash from financing

-₹5.73

Net change in cash

-₹0.74

Free cash flow

₹97.59

Lincoln Pharma Ltd technical summary

₹459.8
-0.28 ▼
2
Bearish
14
Bullish
5 Day465.1
10 Day463.7
12 Day463.9
20 Day466.6
26 Day469.2
50 Day480.6
100 Day501.7
200 Day532.9
5 Day467.3
10 Day458.9
12 Day458.2
20 Day466
26 Day470.6
50 Day479.5
100 Day505.8
200 Day533.8

462.78

PIVOT

First support
₹456.27
First resistance
₹467.62
Second support
₹451.43
Second resistance
₹474.13
Third support
₹444.92
Third resistance
₹478.97
RSI
45.26
ADX
14.9
MACD
-5.3
Williams % R
-64.86
Commodity Channel Index (CCI)
-19.4
Date
05 Feb 2026
Same day
8,410
Week
9,029
Month
9,931
1 year
0.95
3 years
0.9
Over 1 month
-6%
Over 1 year
-34.5%
Over 3 months
-11.85%
Over 3 years
13.45%
Over 6 months
-13.75%
Over 6 years
16.13%

Investment Returns

Over 1 Month6%
Over 3 Months11.85%
Over 6 Months13.75%
Over 1 Year34.5%

Lincoln Pharma Ltd Shareholding pattern


Public
45.51%
Promoter holdings
49.77%
FII
4.69%
DII
0.01%
Promoter shares
0%
Promoter sharesShareCategory

Munjal Mahendrabhai Patel

26,78,800 (13.37%)

Shareholding of Promoter and Promoter Group

Ashish Rajanikant Patel

21,22,902 (10.6%)

Shareholding of Promoter and Promoter Group

Rajanikant Gulabdas Patel

7,56,801 (3.78%)

Shareholding of Promoter and Promoter Group

Mahendrabhai Gulabdas Patel

6,75,000 (3.37%)

Shareholding of Promoter and Promoter Group

Sunmed Corporation Llp

5,00,000 (2.5%)

Shareholding of Promoter and Promoter Group

Promoter sharesShareCategory
Munjal Mahendrabhai Patel26,78,800 (13.37%)Shareholding of Promoter and Promoter Group
Ashish Rajanikant Patel21,22,902 (10.6%)Shareholding of Promoter and Promoter Group
Rajanikant Gulabdas Patel7,56,801 (3.78%)Shareholding of Promoter and Promoter Group
Mahendrabhai Gulabdas Patel6,75,000 (3.37%)Shareholding of Promoter and Promoter Group
Sunmed Corporation Llp5,00,000 (2.5%)Shareholding of Promoter and Promoter Group
Kailashben Mahendrabhai Patel4,80,000 (2.4%)Shareholding of Promoter and Promoter Group
Kishor M. Shah4,78,400 (2.39%)Public Shareholding
Downtown Travels Llp4,75,000 (2.37%)Shareholding of Promoter and Promoter Group
Hasmukhbhai Ishwarbhai Patel3,73,600 (1.87%)Shareholding of Promoter and Promoter Group
Anand Arvinbhai Patel3,32,000 (1.66%)Shareholding of Promoter and Promoter Group
Rimo Capital Fund Lp2,66,450 (1.33%)Public Shareholding
Dheeraj Kumar Lohia2,60,816 (1.3%)Public Shareholding
Shivani Ashish Patel2,06,475 (1.03%)Shareholding of Promoter and Promoter Group
Mansi Munjal Patel2,00,000 (1%)Shareholding of Promoter and Promoter Group
Hansaben Arvindbhai Patel1,77,200 (0.88%)Shareholding of Promoter and Promoter Group
Patel Nishitkumar Maheshbhai1,53,400 (0.77%)Shareholding of Promoter and Promoter Group
Dharmisthaben Bhagirath Patel1,24,459 (0.62%)Shareholding of Promoter and Promoter Group
Arvindbhai Gulabdas Patel1,11,000 (0.55%)Shareholding of Promoter and Promoter Group
Downtown Finance Pvt. Ltd.1,06,000 (0.53%)Shareholding of Promoter and Promoter Group
Renukaben Maheshbhai Patel98,047 (0.49%)Shareholding of Promoter and Promoter Group
Patel Aniruddh H86,200 (0.43%)Shareholding of Promoter and Promoter Group
Jigar Hasmukhbhai Patel86,200 (0.43%)Shareholding of Promoter and Promoter Group
Mihir Viththalbhai Patel82,669 (0.41%)Shareholding of Promoter and Promoter Group
Dharmistaben Hasmukhbhai Patel65,003 (0.32%)Shareholding of Promoter and Promoter Group
Nidhi Mahendrabhai Patel54,000 (0.27%)Shareholding of Promoter and Promoter Group
Bhagirathbhai Tribhovandas Patel24,500 (0.12%)Shareholding of Promoter and Promoter Group
Yogeshkumar Ishwerlal Patel309 (0%)Shareholding of Promoter and Promoter Group
Minaben Yogeshkumar Patel365 (0%)Shareholding of Promoter and Promoter Group

About LINCOLN PHARMA LTD

Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, am

Parent Organisation

Indian Private

NSE Symbol

LINCOLN

Founded

1995

LINCOLN PHARMA LTD CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
12 Sept 20251.8Final12 Sept 2025Equity shares
13 Sept 20241.8Final14 Sept 2024Equity shares
15 Sept 20231.5Final16 Sept 2023Equity shares
15 Sept 20221.5Final17 Sept 2022Equity shares
16 Sept 20211.5Final18 Sept 2021Equity shares
05 Mar 20201.5Interim06 Mar 2020Equity shares
19 Sept 20191.5Final21 Sept 2019Equity shares
19 Sept 20181.5Final22 Sept 2018Equity shares
21 Sept 20171.2Final23 Sept 2017Equity shares
23 Sept 20161Final27 Sept 2016Equity shares
23 Sept 20151Final26 Sept 2015Equity shares
25 Sept 20140.6Final27 Sept 2014Equity shares
19 Sept 20130.6Final21 Sept 2013Equity shares
20 Sept 20120.6Final22 Sept 2012Equity shares
22 Sept 20110.6Final24 Sept 2011Equity shares
23 Sept 20101.2Final25 Sept 2010Equity shares
17 Sept 20091.2Final19 Sept 2009Equity shares
18 Sept 20080.24Final20 Sept 2008Equity shares
20 Sept 20070.24Final22 Sept 2007Equity shares
14 Sept 20060Final16 Sept 2006Equity shares
25 Aug 20050Final29 Aug 2005Equity shares

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)